Tham khảo Gestodene

  1. 1 2 3 4 5 6 7 8 9 Daniel R. Mishell (10 tháng 11 năm 1999). Progestins and Antiprogestins in Clinical Practice. Taylor & Francis. tr. 133–151. ISBN 978-0-8247-8291-7. 
  2. 1 2 Stanczyk FZ (2002). “Pharmacokinetics and potency of progestins used for hormone replacement therapy and contraception”. Rev Endocr Metab Disord 3 (3): 211–24. PMID 12215716. doi:10.1023/A:1020072325818. 
  3. ↑ Fotherby K (tháng 8 năm 1996). “Bioavailability of orally administered sex steroids used in oral contraception and hormone replacement therapy”. Contraception 54 (2): 59–69. PMID 8842581. doi:10.1016/0010-7824(96)00136-9. 
  4. 1 2 3 4 5 6 7 8 9 10 Kuhl H, Jung-Hoffmann C, Wiegratz I (tháng 12 năm 1995). “Gestodene-containing contraceptives”. Clin Obstet Gynecol 38 (4): 829–40. PMID 8616979. doi:10.1097/00003081-199538040-00018. 
  5. 1 2 3 4 J. Elks (14 tháng 11 năm 2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer. tr. 595–. ISBN 978-1-4757-2085-3. 
  6. 1 2 3 I.K. Morton; Judith M. Hall (31 tháng 10 năm 1999). Concise Dictionary of Pharmacological Agents: Properties and Synonyms. Springer Science & Business Media. tr. 132–. ISBN 978-0-7514-0499-9. 
  7. 1 2 3 4 5 6 “Estradiol/gestodene - Bayer Healthcare Pharmaceuticals - AdisInsight”. adisinsight.springer.com. 
  8. 1 2 3 4 5 6 7 8 9 10 11 12 13 “Gestodene - Drugs.com”. drugs.com. 
  9. 1 2 3 4 5 6 7 8 9 10 11 12 13 Kuhl H (2005). “Pharmacology of estrogens and progestogens: influence of different routes of administration” (PDF). Climacteric. 8 Suppl 1: 3–63. PMID 16112947. doi:10.1080/13697130500148875. 
  10. 1 2 3 Fuhrmann, Ulrike; Slater, Emily P.; Fritzemeier, Karl-Heinrich (1995). “Characterization of the novel progestin gestodene by receptor binding studies and transactivation assays”. Contraception 51 (1): 45–52. ISSN 0010-7824. PMID 7750284. doi:10.1016/0010-7824(94)00003-F. 
  11. 1 2 3 4 5 Schindler, Adolf E; Campagnoli, Carlo; Druckmann, René; Huber, Johannes; Pasqualini, Jorge R; Schweppe, Karl W; Thijssen, Jos H.H (2003). “Classification and pharmacology of progestins”. Maturitas 46: 7–16. ISSN 0378-5122. PMID 14670641. doi:10.1016/j.maturitas.2003.09.014. 
  12. 1 2 Benno Clemens Runnebaum; Thomas Rabe; Ludwig Kiesel (6 tháng 12 năm 2012). Female Contraception: Update and Trends. Springer Science & Business Media. tr. 13–. ISBN 978-3-642-73790-9. 
  13. ↑ Howard J.A. Carp (9 tháng 4 năm 2015). Progestogens in Obstetrics and Gynecology. Springer. tr. 112. ISBN 978-3-319-14385-9. 
  14. ↑ Kenneth L. Becker (2001). Principles and Practice of Endocrinology and Metabolism. Lippincott Williams & Wilkins. tr. 1024–. ISBN 978-0-7817-1750-2. 
  15. ↑ Qi Jiang; Weili He (25 tháng 5 năm 2016). Benefit-Risk Assessment Methods in Medical Product Development: Bridging Qualitative and Quantitative Assessments. CRC Press. tr. 135–. ISBN 978-1-4822-5937-7. 
  16. ↑ http://dermnetnz.org/treatments/antiandrogens.html
  17. ↑ Festin (2006). “Progestogens in combined oral contraceptives for contraception”. The WHO Reproductive Health Library. 
  18. ↑ Cerel-Suhl (1999). “Update on Oral Contraceptive Pills”. American Family Physician 60 (7): 2073–2084. 
  19. ↑ “Archived copy” (PDF). Bản gốc (PDF) lưu trữ ngày 22 tháng 7 năm 2011. Truy cập ngày 20 tháng 4 năm 2011. 
  20. ↑ Lidegaard và đồng nghiệp (2011). “Risk of venous thromboembolism from use of oral contraceptives containing different progestogens and oestrogen doses”. BMJ 343: 1–15. PMC 3202015. PMID 22027398. doi:10.1136/bmj.d6423. 
  21. ↑ Sven O. Skouby (15 tháng 7 năm 1997). Clinical Perspectives on a New Gestodene Oral Contraceptive Containing 20μg of Ethinylestradiol. CRC Press. tr. 19–. ISBN 978-1-85070-786-8. 
  22. 1 2 Benagiano G, Primiero FM, Farris M (2004). “Clinical profile of contraceptive progestins”. Eur J Contracept Reprod Health Care 9 (3): 182–93. PMID 15697108. doi:10.1080/13625180400007736. 
  23. 1 2 Donna Shoupe; Florence P. Haseltine (6 tháng 12 năm 2012). Contraception. Springer Science & Business Media. tr. 62–. ISBN 978-1-4612-2730-4. 
  24. ↑ Schindler AE, Campagnoli C, Druckmann R, Huber J, Pasqualini JR, Schweppe KW, Thijssen JH (2008). “Classification and pharmacology of progestins”. Maturitas 61 (1–2): 171–80. PMID 19434889. doi:10.1016/j.maturitas.2008.11.013. 
  25. 1 2 3 4 5 6 7 Stanczyk FZ, Archer DF (2014). “Gestodene: a review of its pharmacology, potency and tolerability in combined contraceptive preparations”. Contraception 89 (4): 242–52. PMID 24485094. doi:10.1016/j.contraception.2013.12.003. 
  26. ↑ Arowojolu, AO; Gallo, MF; Lopez, LM; Grimes, DA (11 tháng 7 năm 2012). “Combined oral contraceptive pills for treatment of acne.”. The Cochrane Database of Systematic Reviews (7): CD004425. PMID 22786490. doi:10.1002/14651858.CD004425.pub6. 
  27. ↑ Lemus AE, Zaga V, Santillán R, García GA, Grillasca I, Damián-Matsumura P, Jackson KJ, Cooney AJ, Larrea F, Pérez-Palacios G (2000). “The oestrogenic effects of gestodene, a potent contraceptive progestin, are mediated by its A-ring reduced metabolites”. J. Endocrinol. 165 (3): 693–702. PMID 10828854. doi:10.1677/joe.0.1650693. 
  28. ↑ Thomas L. Lemke; David A. Williams (2008). Foye's Principles of Medicinal Chemistry. Lippincott Williams & Wilkins. tr. 1316–. ISBN 978-0-7817-6879-5. 
  29. ↑ Jerome Frank Strauss; Robert L. Barbieri (2009). Yen and Jaffe's Reproductive Endocrinology: Physiology, Pathophysiology, and Clinical Management. Elsevier Health Sciences. tr. 878–. ISBN 978-1-4160-4907-4. 
  30. ↑ Ellen JM, Irwin CE (1996). “Primary care management of adolescent sexual behavior”. Curr. Opin. Pediatr. 8 (5): 442–8. PMID 8946122. doi:10.1097/00008480-199610000-00004. 
  31. ↑ Marc A. Fritz; Leon Speroff (2011). Clinical Gynecologic Endocrinology and Infertility. Lippincott Williams & Wilkins. tr. 966–. ISBN 978-0-7817-7968-5.